Search for: "Jacqueline Berman"
Results 1 - 20
of 63
Sort by Relevance
|
Sort by Date
2 Feb 2024, 3:00 am
Congresswoman Cori Bush Under Investigation for Alleged Misuse of Security Funds MSN – Marianna Sotomayor, Perry Stein, and Jacqueline Alemany (Washington Post) | Published: 1/30/2024 The Justice Department is investigating U.S. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
18 Jan 2024, 10:00 pm
To help define a path forward, Morgan Lewis FDA and healthcare partners Jacqueline Berman, Rebecca Dandeker, Maarika Kimbrell, and Kathleen Sanzo have assembled an in-depth report on drug and biologic developments at the FDA. [read post]
27 Oct 2023, 4:00 am
New House Speaker Mike Johnson Faces Herculean Task of Uniting Republicans MSN – Marianna Sotomayor, Amy Wang, Leigh Ann Caldwell, Theodoric Meyer, and Jacqueline Alemany (Washington Post) | Published: 10/25/2023 Rep. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
26 Oct 2023, 10:00 pm
Partners Jacqueline Berman and Maarika Kimbrell wrote an article for Law360 summarizing draft guidance from the US Food and Drug Administration that revises its approach to the dissemination of scientific information on unapproved uses (SIUU) of approved or cleared medical products. [read post]
26 Oct 2023, 4:00 am
” by Hosam Elattar for Voice of OC Michigan: “Financial Disclosures Proposed for Michigan Politicians Are ‘Pretty Weak,’ Advocates Say” by Simon Schuster for MLive Legislative Issues National: “New House Speaker Mike Johnson Faces Herculean Task of Uniting Republicans” by Marianna Sotomayor, Amy Wang, Leigh Ann Caldwell, Theodoric Meyer, and Jacqueline Alemany (Washington Post) for MSN Lobbying National: “An… [read post]
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that while many provisions of the US Congress’ FY 2023 Consolidated Appropriations Act (Omnibus) have received attention, one provision has flown under the radar. [read post]
17 Apr 2023, 10:00 pm
Partners Kathleen Sanzo, Jacqueline Berman, and David Salmons wrote a Law360 Expert Analysis article. [read post]
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that while many provisions of the US Congress’ FY 2023 Consolidated Appropriations Act (Omnibus) have received attention, one provision has flown under the radar. [read post]
17 Apr 2023, 10:00 pm
Partners Kathleen Sanzo, Jacqueline Berman, and David Salmons wrote a Law360 Expert Analysis article. [read post]
17 Apr 2023, 10:00 pm
In an article for Clinical Leader , partner Jacqueline Berman and associate Angela Silva report that while many provisions of the US Congress’ FY 2023 Consolidated Appropriations Act (Omnibus) have received attention, one provision has flown under the radar. [read post]
